MindMed to Participate at September Investor Conferences
28 August 2023 - 9:30PM
Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED)
(the “Company” or “MindMed”), a clinical stage biopharmaceutical
company developing novel product candidates to treat brain health
disorders, announced today that members of the Company’s management
team will participate in the following investor conferences:
- H.C. Wainwright Annual Global Investment Conference
- Format: Fireside Chat
- Dates: September 11-13, 2023
- Webcast Link: H.C. Wainwright Annual Global Investment
Conference
- Cantor Global Healthcare Conference
- Format: Investor Presentation
- Dates: September 26-28, 2023
- Webcast Link: Cantor Global Healthcare Conference
Audio webcasts and replays of available presentations will be
accessible on MindMed’s Investor Resources website for up to 90
days following each event.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders.
MindMed trades on NASDAQ under the symbol MNMD and on the
Canadian NEO Exchange under the symbol MMED.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230828378219/en/
For Media & Investor Inquiries, please contact:
Maxim Jacobs, CFA Vice President, Investor Relations and
Corporate Communications Mind Medicine (MindMed) Inc. ir@mindmed.co
media@mindmed.co
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Apr 2024 to May 2024
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From May 2023 to May 2024